FineMark National Bank & Trust’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-6,383
Closed -$512K 1243
2016
Q4
$512K Sell
6,383
-2,648
-29% -$210K 0.04% 212
2016
Q3
$720K Sell
9,031
-661
-7% -$53.4K 0.08% 171
2016
Q2
$756K Sell
9,692
-1,608
-14% -$115K 0.08% 170
2016
Q1
$622K Sell
11,300
-80
-0.7% -$4.36K 0.07% 179
2015
Q4
$703K Sell
11,380
-100
-0.9% -$6.31K 0.08% 163
2015
Q3
$724K Hold
11,480
0.1% 163
2015
Q2
$839K Sell
11,480
-460
-4% -$33.2K 0.11% 165
2015
Q1
$781K Sell
11,940
-550
-4% -$36.6K 0.11% 169
2014
Q4
$812K Hold
12,490
0.12% 161
2014
Q3
$751K Hold
12,490
0.12% 160
2014
Q2
$865K Buy
12,490
+600
+5% +$38.9K 0.15% 145
2014
Q1
$777K Sell
11,890
-20,256
-63% -$1.32M 0.15% 146
2013
Q4
$1.99M Buy
32,146
+3,633
+13% +$210K 0.41% 59
2013
Q3
$1.53M Buy
28,513
+9,671
+51% +$498K 0.38% 66
2013
Q2
$864K Buy
+18,842
New +$816K 0.26% 83

Other funds holding STJ

FineMark National Bank & Trust's STJ Position: Q1 2017 in Review

FineMark National Bank & Trust sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 6,383 shares — an estimated $512K sold.

FineMark National Bank & Trust first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $1.99M in Q4 2013. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • FineMark National Bank & Trust reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • FineMark National Bank & Trust sold 6,383 St Jude Medical shares in Q1 2017, an estimated $512K.
  • FineMark National Bank & Trust first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
  • FineMark National Bank & Trust's St Jude Medical position peaked at $1.99M in Q4 2013.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on FineMark National Bank & Trust's 13F filing for Q1 2017, filed 12 May 2017.